Larvol Delta - 1ST-Biotherapeutics-Inc-Announces-FDA-Clearance-of-IND-Application-for-Phase-12-Study-of-FB849-to-Treat-Patients-with-Advanced-Solid-Tumors

FB849 - 1ST Bio

https://www.globenewswire.com/news-release/2022/12/13/2572399/0/en/1ST-Biotherapeutics-Inc-Announces-FDA-Clearance-of-IND-Application-for-Phase-1-2-Study-of-FB849-to-Treat-Patients-with-Advanced-Solid-Tumors.html

Dec 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next